As the pandemic continues to play out, test developers aren't sure how it will impact STIs and their work around developing and manufacturing tests.
Labs and commercial developers have created simple, inexpensive PCR assays for the SARS-CoV-2 Delta variant that they say could help surveillance efforts.
SpeeDx Gets Regulatory Approval in Australia for COVID-19 Molecular Test Kit
The assay detects two regions of the SARS-CoV-2 virus that the firm claims are unaltered in all currently circulating variants.
SpeeDx, MolGen Partner for COVID-19 Testing
The agreement connects SpeeDx chemistry with MolGen's equipment for a fully integrated, high-throughput sample-to-answer workflow, the firms said.
Nov 17, 2020
Feb 11, 2020
SpeeDx Raises Additional $15M
Jan 13, 2020
SpeeDx, LabCorp Will Codevelop MDx Tests
Aug 5, 2019
SpeeDx Raises $15M in Equity Investment
Jun 24, 2019
SpeeDx, GSK Sign Test Supply, Development Deal
Apr 15, 2019
Mar 18, 2019
SpeeDx Signs Distributor Deals in Middle East
Jan 23, 2019
SpeeDx Signs Distribution Deals in Finland, Italy
Nov 8, 2018
SpeeDx Signs Distributions Deals Across Europe
Apr 23, 2018